UY30171A1 - Formas cristalinas de n- (benzo (b) tien-3-ilmetil) -sulfamida - Google Patents

Formas cristalinas de n- (benzo (b) tien-3-ilmetil) -sulfamida

Info

Publication number
UY30171A1
UY30171A1 UY30171A UY30171A UY30171A1 UY 30171 A1 UY30171 A1 UY 30171A1 UY 30171 A UY30171 A UY 30171A UY 30171 A UY30171 A UY 30171A UY 30171 A1 UY30171 A1 UY 30171A1
Authority
UY
Uruguay
Prior art keywords
benzo
sulfamida
ilmetil
tien
crystal forms
Prior art date
Application number
UY30171A
Other languages
English (en)
Inventor
Bruce E Maryanoff
Allen B Reitz
Michael H Parker
Nagy Fawzy
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38066512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30171(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY30171A1 publication Critical patent/UY30171A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencinn se refiere a formas cristalinas, anhidras y solvatadas de N-(benzo(b)tien-3-(ilmetil)-sulfamida, composiciones farmaccuticas que contienen dichas formas cristalinas y su utilizacinn en el tratamiento de la epilepsia y trastornos relacionados.
UY30171A 2006-02-22 2007-02-22 Formas cristalinas de n- (benzo (b) tien-3-ilmetil) -sulfamida UY30171A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77572406P 2006-02-22 2006-02-22

Publications (1)

Publication Number Publication Date
UY30171A1 true UY30171A1 (es) 2007-07-31

Family

ID=38066512

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30171A UY30171A1 (es) 2006-02-22 2007-02-22 Formas cristalinas de n- (benzo (b) tien-3-ilmetil) -sulfamida

Country Status (6)

Country Link
US (1) US20070232685A1 (es)
AR (1) AR059596A1 (es)
PE (1) PE20071016A1 (es)
TW (1) TW200738669A (es)
UY (1) UY30171A1 (es)
WO (1) WO2007098486A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
JP2008545650A (ja) 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EA200870556A1 (ru) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
CA2696253A1 (en) 2007-08-08 2009-02-12 Janssen Pharmaceutica Nv Sulfamide derivative useful for the treatment of epilepsy
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
WO2009120191A1 (en) * 2008-03-26 2009-10-01 Janssen Pharmaceutica N.V. Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide
NZ590682A (en) 2008-06-23 2012-09-28 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
WO1997019682A1 (en) * 1995-12-01 1997-06-05 Synaptic Pharmaceutical Corporation Aryl sulfonamide and sulfamide derivatives and uses thereof
WO2002096424A1 (en) * 2001-05-25 2002-12-05 Queen's University At Kingston Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents
US20030047001A1 (en) * 2001-08-28 2003-03-13 Grace Liao Ball speed detecting assembly
CN1897950A (zh) * 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
TW200612905A (en) * 2004-06-16 2006-05-01 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2005277134A1 (en) * 2004-08-24 2006-03-02 Janssen Pharmaceutica N.V. Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
JP2008545650A (ja) * 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法

Also Published As

Publication number Publication date
AR059596A1 (es) 2008-04-16
TW200738669A (en) 2007-10-16
US20070232685A1 (en) 2007-10-04
WO2007098486A1 (en) 2007-08-30
PE20071016A1 (es) 2007-10-24

Similar Documents

Publication Publication Date Title
UY30171A1 (es) Formas cristalinas de n- (benzo (b) tien-3-ilmetil) -sulfamida
ECSP077275A (es) Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos
ECSP067093A (es) Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados
PA8759501A1 (es) Formas cristalinas
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
UY30359A1 (es) Coterapeutica para el tratamiento de epilepsia y trastornos relacionados i
MX2010005298A (es) Compuestos de carboxamida, sulfonamida y amina para trastornos metabolicos.
BRPI0812456A2 (pt) " dispositivo de iluminação e dispositivo de display de cristal líquido ".
CR20110042A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo [1,4]dioxin-2-ilmetil)-sulfamida
GT200600260A (es) Derivados de benzamida y usos relacionados con los mismos
CR9225A (es) Derivados del pirimidinil y piridinil sustituidos como moduladores del metabolismo y el tratamiento de desordenes relacionados con el mismo
ECSP088904A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
UY30360A1 (es) Coterapeutica para el tratamiento de epilepsia y trastornos relacionados ii
ECSP099720A (es) Moduladores de gamma-secretasa
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
MA28707B1 (fr) Utilisation de 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines substituees lors du traitement de nausees et de vomissements
ECSP099776A (es) Moduladores de la gamma secretasa
BRPI0620229A8 (pt) formulação
CR10060A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
AR057148A1 (es) Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
ATE531703T1 (de) Benzochromenderivate
CO6382113A2 (es) Compuestos quimicos
AR062475A1 (es) Combinaciones farmacologicas para el tratameinto de enfermedades de las vias aereas
GT200600421A (es) Formas cristalinas polimórficas de la sal de di-sodio del ácido n-(5-clorosaliciloil)-8-aminocaprilico